The University of Chicago Header Logo

Joseph Cannova

TitleInstructor
InstitutionUniversity of Chicago
DepartmentMedicine-Hematology and Oncology
AddressChicago IL 60637
Phone+1 (773) 8346564
ORCID ORCID Icon0000-0002-9986-1999 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lachowiez CA, Zeidner JF, Othman J, Kaempf A, Yun S, Heiblig M, Heuser M, Shahswar R, Madero Marroquin R, Cannova JM, Žucenka A, Marvin-Peek J, Senapati J, Abaza Y, Swaroop A, Zacheo I, Monaco F, Belhabri A, Tauveron-Jalenques U, Tavernier E, Carré M, Aspas Requena G, Cook RJ, Traer E, Saultz JN, O'Nions J, Basheer F, Laurie J, Handa S, Stein EM, Baer MR, Olin R, Blum W, Schiller G, Lin T, Curran E, Yocum A, Madarang E, Daver N, Kadia TM, Marconi G, Madanat Y, Dillon R, DiNardo CD, Swords R, Arango Ossa JE, Watts J, Loghavi S, Pollyea DA, Bernard E, PRISM-AML Investigators. Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model. J Clin Oncol. 2026 Jul 02; JCO2600347. PMID: 42391582.
      Citations:    Fields:    
    2. Cannova JM, DuVall AS, Kline J, Feinberg N, Wool GD, Riedell PA. Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients. J Natl Compr Canc Netw. 2026 Feb 19; 24(3):128-131. PMID: 41771248; PMCID: PMC13077976.
      Citations:    Fields:    Translation:Humans
    3. Ramsland AS, Dudek K, McNeely KE, Cannova JM, Khosravi Z, Burnett J, Gilad Y, Godley LA, Griffiths EA, Drazer MW. Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutation. Stem Cell Res. 2026 Mar; 91:103919. PMID: 41643484.
      Citations:    Fields:    Translation:HumansCells
    4. Cannova JM, Battaglia MR, Roloff GW, Cetin S, Tallarico M, Stock W, Patel AA, Odenike O, Larson RA, Thirman MJ, Nawas MT, Wang P, Tjota MY, Segal JP, Venkataraman G, DuVall AS, Drazer MW. Hematologic complications in patients exposed to poly- ADP ribose polymerase inhibitors. Haematologica. 2026 Jul 01; 111(7):2451-2456. PMID: 41609051.
      Citations:    Fields:    
    5. Madero-Marroquin R, Cannova J, Dworkin E, Wesevich A, Roloff GW, Saygin C, Nawas MT, DuVall AS, Kosuri S, Thirman MJ, Odenike O, Stock W, Larson RA, Drazer MW, Patel AA. Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy. EJHaem. 2025 Jun; 6(3):e70078. PMID: 40521395; PMCID: PMC12163342.
      Citations:    
    6. Cannova J, Drazer MW. Germ line JAK2 variants and hereditary blood cancers. Blood Adv. 2025 Apr 08; 9(7):1585-1586. PMID: 40152887; PMCID: PMC12138511.
      Citations: 1     Fields:    
    7. Cannova J, Madero-Marroquin R, Odenike O. Imetelstat: drugging telomerase in transfusion-dependent low- and intermediate-1-risk MDS. Blood Adv. 2025 Mar 25; 9(6):1390-1391. PMID: 39776158; PMCID: PMC11957495.
      Citations:    Fields:    
    8. Cannova J, Shah S, Patel AA. SOHO State of the Art Updates and Next Questions | Challenging Scenarios in the Management of Myeloproliferative Neoplasms. Clin Lymphoma Myeloma Leuk. 2025 Jul; 25(7):484-493. PMID: 40050145; PMCID: PMC12146093.
      Citations:    Fields:    Translation:Humans
    9. Battaglia MR, Cannova J, Madero-Marroquin R, Patel AA. Correction to: Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome. Curr Treat Options Oncol. 2024 Oct; 25(10):1335. PMID: 39312157.
      Citations:    Fields:    
    10. Battaglia MR, Cannova J, Madero-Marroquin R, Patel AA. Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome. Curr Treat Options Oncol. 2024 Jun; 25(6):752-768. PMID: 38814537; PMCID: PMC13098679.
      Citations: 5     Fields:    Translation:Humans
    11. Saygin C, Cannova J, Stock W, Muffly L. Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. Haematologica. 2022 12 01; 107(12):2783-2793. PMID: 36453516; PMCID: PMC9713546.
      Citations: 40     Fields:    Translation:Humans
    12. Li J, Volk A, Zhang J, Cannova J, Dai S, Hao C, Hu C, Sun J, Xu Y, Wei W, Breslin P, Nand S, Chen J, Kini A, Zhu J, Zhang J. Sensitizing leukemia stem cells to NF-?B inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling. Oncotarget. 2017 Jan 31; 8(5):8420-8435. PMID: 28039479; PMCID: PMC5352411.
      Citations: 22     Fields:    Translation:HumansAnimalsCells
    13. Liang K, Volk AG, Haug JS, Marshall SA, Woodfin AR, Bartom ET, Gilmore JM, Florens L, Washburn MP, Sullivan KD, Espinosa JM, Cannova J, Zhang J, Smith ER, Crispino JD, Shilatifard A. Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia. Cell. 2017 Jan 12; 168(1-2):59-72.e13. PMID: 28065413; PMCID: PMC5351781.
      Citations: 69     Fields:    Translation:HumansAnimalsCells
    14. Xin J, You D, Breslin P, Li J, Zhang J, Wei W, Cannova J, Volk A, Gutierrez R, Xiao Y, Ni A, Ng G, Schmidt R, Xia Z, Pan J, Chen H, Patel MM, Kuo PC, Nand S, Kini AR, Zhang J, Chen J, Zhu J, Zhang J. Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway. Leukemia. 2017 May; 31(5):1154-1165. PMID: 27748372; PMCID: PMC5457287.
      Citations: 31     Fields:    Translation:HumansCells
    15. Xin J, Breslin P, Wei W, Li J, Gutierrez R, Cannova J, Ni A, Ng G, Schmidt R, Chen H, Parini V, Kuo PC, Kini AR, Stiff P, Zhu J, Zhang J. Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in mice. Haematologica. 2017 02; 102(2):295-307. PMID: 27634200; PMCID: PMC5286937.
      Citations: 13     Fields:    Translation:AnimalsCells
    16. Cannova J, Breslin S J P, Zhang J. Toll-like receptor signaling in hematopoietic homeostasis and the pathogenesis of hematologic diseases. Front Med. 2015 Sep; 9(3):288-303. PMID: 26297301.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    Cannova's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (83)
    Explore
    _
    Co-Authors (14)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _